Resources

Silva A. Arslanian, MD, explains the rigorous process for gaining approval for new diabetes drugs for children, and points out that the type 2 rate is not yet at epidemic proportions in children (as it is in adults)….

With all of the discussion in the medical community and beyond regarding new drug approvals for diabetes, it is easy to forget that many of these drugs are not approved for children and adolescents. Silva A. Arslanian, MD, Professor of Pediatrics, University of Pittsburgh School of Medicine, explains why this is and describes …

Dr. Arslanian talks about the earlier incidence rate of ESRD of people who have type 2 in childhood as well as her own team’s studies on cardiovascular markers, and the premature “aging” of the CV system seen in these individuals. She also discusses the challenges of children growing up in …

Dr. Arslanian introduces herself and describes her recent research and the “sobering reality” of researching type 2 in children and adolescents.  More videos with Dr. Arslanian: T2DM in Children – Earlier co-morbidities? What drugs can be prescribed to children with diabetes? How does the drug approval process differ for children? …

Dr. Langer tells us exactly what he wants his A1c to be. More videos with Dr. Langer: Oded Langer, MD, PhD, Introduction Pregnancy and the Safety of Oral Diabetes Medications  What Diabetes Drugs Can Be Used by Pregnant Women with Diabetes?  What Is the Best Test for Blood Glucose Levels …

Dr. Oded Langer, Obstetrician and Gynecologist, Professor at Columbia University, explains that he always tries to follow-up with his GDM patients for the development of type 2 and between 50-80% of them eventually develop the disease. He also stresses the importance of this follow-up for the infant, and that good prevention strategies …

Dr. Langer explains why HbA1c is not a good a test for pregnant women because of the natural changes in a pregnant woman’s blood cells as well as the limited time of the pregnancy (as compared to measuring HbA1c over longer periods of time in a non-pregnant person). He discusses …

Dr. Langer discusses the difficult challenges of researching and introducing new diabetes drugs for pregnant women with either GDM or type 2, including how to determine if a drug can cross the placenta from mother to fetus (giving us some examples), and the importance of monitoring children for potential long-term …

Dr. Oded Langer, Obstetrician and Gynecologist, Professor at Columbia University, gives us an overview on the paper he presented at AACE, the specific drugs — metformin and glyburide — which his team has researched, and some of the results of his studies. More videos with Dr. Langer: Oded Langer, MD, PhD, Introduction …

Dr. Langer introduces himself and what he is working on currently. More videos with Dr. Langer: Pregnancy and the Safety of Oral Diabetes Medications  What Diabetes Drugs Can Be Used by Pregnant Women with Diabetes?  What Is the Best Test for Blood Glucose Levels in Diabetic Women? Do Many of …